Serum and tissue levels of matrix metalloproteinase-1 and its tissue inhibitor in patients with intervertebral disc degeneration

doi:10.3969/j.issn.2095-4344.2016.29.007

Abstract

Abstract:

BACKGROUND: Matrix metalloproteinases are now generally considered to be able to degrade all extracellular matrices. Hypersecretion of matrix metalloproteinases or reduction in tissue inhibitors of matrix metalloproteinases leads to destruction of the dynamic balance of extracellular matrix.
OBJECTIVE: To elucidate the role of matrix metalloproteinase-1 and tissue inhibitor of matrix metalloproteinase-1 in the pathogenesis and progression of intervertebral disc degeneration.
METHODS: A total of 60 patients with intervertebral disc degeneration were included. Mild, moderate, and severe degeneration signals appeared on MRI imaging of the patients. Meanwhile, 20 patients with vertebral fracture, mainly cervical spine fracture, were selected as the control group. Venous blood samples were collected before the surgery; the intervertebral disc specimens were sequentially collected.
RESULTS AND CONCLUSION: Serum and tissue levels of matrix metalloproteinase-1 in patients with intervertebral disc degeneration were significantly increased compared with the control group (P < 0.05), and furthermore those were significantly increased in patients with severe disc degeneration compared with patients with mild and moderate disc degeneration (P < 0.05). However, serum and tissue levels of tissue inhibitors of matrix metalloproteinases did not differ significantly between the disc degeneration and control groups (P > 0.05). These results indicate that hypersecretion of matrix metalloproteinase-1 occurs in patients with intervertebral disc degeneration; however, the expression of tissue inhibitor of matrix metalloproteinase-1 is not correlated with intervertebral disc degeneration.

中国组织工程研究杂志出版内容重点：组织构建；骨细胞；软骨细胞；细胞培养；成纤维细胞；血管内皮细胞；骨质疏松；组织工程

Key words: Matrix Metalloproteinases, Spine, Intervertebral Disk, Tissue Engineering

CLC Number:

R318

Deng Bin, Wang Ye-xin, Meng Chun-yang. Serum and tissue levels of matrix metalloproteinase-1 and its tissue inhibitor in patients with intervertebral disc degeneration[J]. Chinese Journal of Tissue Engineering Research, 2016, 20(29): 4303-4310.

Figures/Tables 2

References

[1] Baliga S,Treon K,Craig NJ.Low Back Pain: Current Surgical Approaches. Asian Spine J. 2015;9(4): 645-657.
[2] 黄庆华.椎间盘退变分子机制的研究进展[J].医学信息(中旬刊).2011,24(4)：1672-1674.
[3] Lotz JC,Colliou OK,Chin JR,et al. Compression- induced changes in intervertebral disc properties in a rat tail model.Spine.1999;24:996-1002.
[4] Rastogi A, Kim H, Twomey JD, et al.MMP-2 mediates local degradation and remodeling of collagen by annulus fibrosus cells of the intervertebral disc. Arthritis Res Ther.2013;15(2):R57.
[5] Leung VY, Tam V, Chan D, et al.Tissue engineering for intervertebral disk degeneration. Orthop Clin North Am. 2011;42(4): 575-583.
[6] Hulboy DL,Rudolph LA,Mamsian LM. Metalloproteinase as mediators of reproductive functionI．Mol Hum Reprod.1997;3:27-45．
[7] Baillet A,Grange L,Trocmé C,et al.Differences in MMPs and TIMP-1 expression between intervertebral disc and disc herniation. Joint Bone Spine.2013;80(3): 341-342.
[8] Zou J,Huang GF,Zhang Q,et al.Effects of electroacupuncture stimulation of "Jiaji" (EX-B 2) on expression of matrix metalloproteinase-13 and tissue inhibitor of metalloproteinase-1 in intervertebral disc tissue in rabbits with lumbar intervertebral disc degeneration. Zhen Ci Yan Jiu. 2014;39(3): 192-197.
[9] Gruber HE, Hoelscher GL,Ingram JA,et al.Matrix metalloproteinase-26, a novel MMP, is constitutively expressed in the human intervertebral disc in vivo and in vitro. Exp Mol Pathol.2012;92(1):59-63.
[10] 刘海心,王德春,胡有谷.椎间盘的营养与退变[J].中国矫形外科杂志,2006,14(1):863.
[11] 李小川,李雷.Fas/FasL基因在退变腰椎间盘组织中的表达及诱导凋亡作用[J].中华医学杂志,2005,25(24):1718.
[12] 王守丰,邱勇.生物力学因素对椎体生长板的影响和临床意义[J].中国脊柱脊髓杂志,2006,16(4):301.
[13] Hatano E, Fujita T, Ueda Y, et al. Expression of ADAMTS-4 (aggrecanase-1) and Possible Involvement in Regression of Lumbar Disc Herniation. Spine.2006;31(13):1426.
[14] 王湘达,陈伯华.Ⅳ型胶原在退变椎间盘中的表达及意义[J].青岛大学医学院学报,2003,39(3):318.
[15] Zetser A, Bashenko Y, Miao HQ,et al. Heparanase effects adhesive and tumorigenic potential of human glioma cells. Cancer Res. 2003;63(22):7733-7741.
[16] Wu WP,Jiang JM, Qu DB,et al.Expression of hypoxia-inducible factor-1alpha and matrix metalloproteinase-2 in degenerative lumbar intervertebral disc. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30(5):1152-1155.
[17] Mavrogonatou E, Angelopoulou MT, Kletsas D.The catabolic effect of TNFalpha on bovine nucleus pulposus intervertebral disc cells and the restraining role of glucosamine sulfate in the TNFalpha-mediated up-regulation of MMP-3. J Orthop Res.2014;32(12): 1701-1707.
[18] Yuan Y,Zhao J,Li YM, et al.Expression and significance of NF-κB, MMP-1/TIMP-1 in intervertebral disc degeneration. Shandong Med J. 2011;19: 004.
[19] Canbay S, Turhan N, Bozkurt M, et al.Correlation of matrix metalloproteinase-3 expression with patient age, magnetic resonance imaging and histopathological grade in lumbar disc degeneration. Turk Neurosurg. 2013; 23(4):427-233.
[20] Gomis-Rüth FX. Catalytic domain architecture of metzincin metalloproteases.J Biol Chem. 2009；284(23): 15353-15357.
[21] Zawilla NH, Darweesh H, Mansour N, et al.Matrix metalloproteinase-3, vitamin D receptor gene polymorphisms, and occupational risk factors in lumbar disc degeneration. J Occup Rehabil.2014;24(2): 370-381.
[22] Valdes AM, Hassett G, Hart DJ, et al.Radiographic Progression of Lumbar Spine Disc Degeneration Is Influenced by Variation at Inflammatory Genes: A Candidate SNP Association Study in the Chingford Cohort. Spine (Phila Pa 1976). 2005;30(21): 2445-2451.
[23] Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res.2003; 92(8): 827-839.
[24] Zcharia E, Zilka R, Yaar A, et al. Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models. FASEB J.2005;19: 211-221.
[25] Wolf M, Lommes P, Sock E, Reiprich S,et al. Replacement of related POU transcription factors leads to severe defects in mouse forebrain development. Dev Biol.2009;332: 418-428.
[26] Takebayashi-Suzuki K, Arita N, Murasaki E,et al.The Xenopus POU class V transcription factor XOct-25 inhibits ectodermal competence to respond to bone morphogenetic protein-mediated embryonic induction. 2007;124: 840-855.
[27] Sotnikov I, Hershkoviz R, Grabovsky V,et al. Enzymatically quiescent heparanase augments T cell interactions with VCAM-1 and extracellular matrix components under versatile dynamic contexts. J Immunol 2004;172: 5185-5193.
[28] 魏见伟,王德春,胡有谷．基质金属蛋白酶及其抑制因子与腰椎间盘退变关系的研究进展[J].中国脊柱脊髓杂志, 2006,16(4):304.
[29] Bachmeier BE，Nerlich A，Mittennaler N，et al，Matrix metallopreteinase expression levels suggest distinct enzyme roles during 1umbar discherniation and degeneration.Eur Spine J.2009;18:1573-1586.
[30] Kanemoto M,Hukuda S,Komiya Y,et al. Innnunohistochemical study of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in human intervertebral disc. Spine.1996;21:1-8．
[31] Kimura K, Cheng XW, Nakamura K,et al.Matrix metalloproteinase‐2 regulates the expression of tissue inhibitor of matrix metalloproteinase‐2. Clin Exp Pharmacol Physiol. 2010;37(11):1096-1101.
[32] Carvalho RV, Ogliari FA, de Souza AP,et al.2‐Hydroxyethyl methacrylate as an inhibitor of matrix metalloproteinase-2. Eur J Oral Sci. 2009;117(1): 64-67.
[33] Pockert AJ, Richardson SM, Le Maitre CL,et al. Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis&Rheumatism. 2009;60(2): 482-491.
[34] Vo NV, Hartman RA, Yurube T, et al.Expression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degeneration.Spine J. 2013;13(3): 331-341.
[35] Yurube T, Takada T, Suzuki T, et al.Rat tail static compression model mimics extracellular matrix metabolic imbalances of matrix metalloproteinases, aggrecanases, and tissue inhibitors of metalloproteinases in intervertebral disc degeneration. Arthritis Res Ther.2012;14(2):R51.
[36] Furtwängler T, Chan SC, Bahrenberg G, et al. Assessment of the matrix degenerative effects of MMP-3, ADAMTS-4, and HTRA1, injected into a bovine intervertebral disc organ culture model. Spine (Phila Pa 1976).2013;38(22): E1377-1387.